Tytuł artykułu
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
Torsemide (TSM) is a loop diuretic used in the treatment of edema, and spironolactone (SPL) is a potassium-sparing diuretic used in hypokalemia. Both are potential diuretics used in combination to treat congestive heart failure. This paper describes a simple, sensitive, accurate, and validated reverse-phase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous quantification of these compounds as the bulk drug and in tablet dosage forms. Separation was carried out on Jasco HPLC system equipped with Neosphere C8 column (150 × 4.6 mm i.d.) and UV/VIS detector using acetonitrile:10 mM potassium dihydrogen phosphate buffer in ratio of 60:40 (υ/υ) as the mobile phase, and detection was carried out at 240 nm. Results were linear in the range of 2–12 μg mL-1 for TSM and 5–30 μg mL-1 for SPL. The method was successfully applied for the analysis of drugs in pharmaceutical formulation. Results of the analysis were validated statistically and by recovery studies.
Słowa kluczowe
Czasopismo
Rocznik
Tom
Strony
15--22
Opis fizyczny
Bibliogr. 12 poz., rys., tab.
Twórcy
autor
- A.I.S.S.M.S. College of Pharmacy Department of Pharmaceutical Analysis Kennedy Road Pune 411001 MH India
autor
- A.I.S.S.M.S. College of Pharmacy Department of Pharmaceutical Analysis Kennedy Road Pune 411001 MH India
autor
- A.I.S.S.M.S. College of Pharmacy Department of Pharmaceutical Analysis Kennedy Road Pune 411001 MH India
autor
- A.I.S.S.M.S. College of Pharmacy Department of Pharmaceutical Analysis Kennedy Road Pune 411001 MH India
Bibliografia
- [1] http://www.wikipedia.com/torsemide (accessed on 03/02/09)
- [2] http://www.wikipedia.com/spironolactone (accessed on 03/02/09)
- [3] A.S. Jankowski and H. Lamparczyk, J. Pharm. Biomed. Anal., 14, 1359 (1996)
- [4] J.W. Overdiek, W.A. Hermens, and F.W. Merkus, J. Chromatogr. B, 341, 279 (2002)
- [5] R. Herráez-Hernández, E. Soriano-Vega, and P. Campíns-Falc, J. Chromatogr. B, 658, 303 (2002)
- [6] J.H. Sherry, J.P. O’Donnell, and H.D. Colby, J. Chromatogr. B, 374, 183 (2001)
- [7] J.M. Sandall, J.S. Millership, P.S. Collier, and J.C. McElnay, J. Chromatogr. B, 839, 36, (2006)
- [8] D. Erdal and U. Ozgur, Farmaco II, 58, 1151 (2003)
- [9] J.C. Millership, C. Parker, and D. Donnelly, Farmaco II, 60, 333 (2005)
- [10] C. March, D. Farthing, B. Wells, and T. Karnes, J. Pharm. Sci., 79, 453 (1990)
- [11] D. Zendelovska and T. Stafilov, Acta Pharm., 56, 115 (2006)
- [12] International Conference on Harmonization, ICH harmonised tripartite guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), ICH, Geneva, Nov 2005
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-2c77e90d-3820-4019-83c6-4f8e7b573729